Skip to content
PICO Portalanswers from OpenAlex

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients

PaperCitations, authors & open-access status

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients is a paper indexed in PICO Portal from OpenAlex.

How many citations does Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients have?

PICO Portalcitation count

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients has 229 citations in the OpenAlex counts PICO Portal stores.

When was Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients published?

PICO Portalyear

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients has 2019 year in the PICO Portal index.

What is the open-access status of Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients?

PICO Portaloa status

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients has gold oa status in the PICO Portal index.

What is the DOI of Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients?

PICO Portaldoi

The DOI for Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients is on the source record.

What is the PMID of Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients?

PICO Portalpmid

The PMID for Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients is on the source record.

What is the OpenAlex record for Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients?

PICO Portalopenalex

The OpenAlex for Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial